Skip to content
Stop using now Drug recall · FDA · Published July 29, 2014

Hospira Lidocaine HCl Recall: Particulate Matter Hazard

Hospira recalls 109,110 vials of Lidocaine HCl Injection due to visible particulates and discoloration. Check lot numbers and expiration dates immediately.

🇺🇸 FDA recall #D-0020-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 109,110 vials of Lidocaine HCl Injection, USP, 2% because the solution was discolored and contained visible particulate matter (iron oxide). These particles were found both in the liquid solution and embedded in the glass vial itself. The recall affects units distributed nationwide with a Class I classification. Read more at govinfonow.com/recall/45926-hospira-inc-recalls-lidocaine-hcl-injection-usp-2-20-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/45926-hospira-inc-recalls-lidocaine-hcl-injection-usp-2-20-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-0020-2015

Cite this page

“Hospira Lidocaine HCl Recall: Particulate Matter Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45926-hospira-inc-recalls-lidocaine-hcl-injection-usp-2-20-mg. Based on FDA recall #D-0020-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0020-2015%22&limit=1).

The FDA announced on 2014-07-29 that Hospira Inc. is recalling Lidocaine HCl Injection Vials due to the presence of particulate matter, including iron oxide and discoloration. The agency classified the recall as Class I.

How to tell if you have it

  • Brand: Hospira
  • Product: Lidocaine HCl Injection Vials
  • NDC: 0409-2066-05
  • Lot Number: 25-550-DD
  • Expiration Date: 1JAN2015
  • Quantity: 109,110 Vials

The hazard

The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial. The FDA classified the recall as Class I.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (2026-07-24), Asclemed Lidocaine HCl Injection Recall (2026-06-08), and Huons Co Lidocaine HCl Injection Recall (2026-04-02).

How to tell if you have this one

Look for Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vials. Check for NDC 0409-2066-05 and Lot Number 25-550-DD with an expiration date of 1JAN2015. The product is manufactured by Hospira, Inc., Lake Forest, IL.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not use any vials matching the recalled lot number or NDC due to the risk of particulate contamination.

  2. Check Lot Numbers

    Verify if your inventory includes Lot Number 25-550-DD and NDC 0409-2066-05 with an expiration of 1JAN2015.

  3. Contact Manufacturer

    Since the remedy is not stated in the record, contact Hospira Inc. directly for further instructions on disposal or return.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.6 years after the firm started it.

1. Firm started the recall: Jul 29, 201412. FDA classified it Class I: Oct 10, 201423. Published in FDA’s Enforcement Report: Oct 22, 201434. FDA terminated the recall: Mar 17, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled product?

The National Drug Code (NDC) is 0409-2066-05.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0020-2015 (July 29, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0020-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA